| |
|
|
|
Oasmia Pharmaceutical AB (publ)  
|
|
1.76 0 (0%) |
08-17 16:00 |
|
Open: |
1.8 |
Pre close: |
1.76 |
Target:
|
2.64
|
|
High: |
1.8 |
Low: |
1.76 |
Resistance:
|
2.26
2.81
|
|
Volume: |
16,107 |
Market Cap: |
109M |
Support:
|
1.36
1.13
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.77
 |
MACD |
MACD(12,26):
|
0.06  |
|
MA(20): |
1.75 |
Signal(12,26,9): |
0.05 |
|
MA(100): |
1.48 |
Stochastic Oscillator |
%K(14,3):
|
44.29 |
|
MA(250): |
0.00 |
%D(3): |
33.77 |
|
Average Volume(K) |
3-Month: |
3725
|
52-Week |
High:
|
3.16 |
|
10-Days: |
1688 |
Low: |
0.80 |
|
RSI |
RSI(14):
|
52.49 |
Change(%): |
67.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.460 |
Return on Equity (ttm) |
-39.0 |
Shares Out. (M) |
59.77 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-23.1 |
Shares Float (M) |
59.77 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
126.1 |
% Held by Institutions |
0.10 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.005 |
Shares Short (K) |
14 |
|
Book Value (p.s.) |
2.510 |
EBITDA (p.s.) |
-0.179 |
P/E |
-3.83 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.70 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-13.92 |
P/S |
15213440000.00 |
|
Operating Margin |
-852.05 |
Levered Free Cash Flow
(M) |
-16.98 |
P/CF |
-7.56 |
|
|
|
|
|
|
